Information on research, events, activities, and news from the T1D community across Canada.
Kaleb Dahlgren joins the #TeamT1D initiative by sharing his thoughts on misconceptions about T1D and the role the Canadian government can play in supporting those living with it.
Administering multiple insulin injections is one of the many daily burdens for people living with type 1 diabetes (T1D) – particularly among those with a needle phobia. However, a team of scientists is hoping to change all that with the development of an insulin pill to manage the condition.
Up until recently, researchers seeking to unlock the mystery of type 1 diabetes (T1D) relied on many different theories. Some stemmed from autopsy-based studies of human pancreas dating back to the 1960s, while others were from investigations of pancreatic material obtained from rodent models for th...
A researcher from Milan, Italy has discovered that neutrophils – a type of white blood cell that forms an essential part of the immune system – can help identify triggers and predictors of progression to type 1 diabetes (T1D).
If you're among those denied the Disability Tax Credit, you may need to reach out to the CRA.
For most people, a power failure is a huge inconvenience. However, for someone living with type 1 diabetes (T1D), it can be a daunting – and potentially fatal – experience since their insulin needs to be kept refrigerated.
We sat down with our JDRF Marketing & Communications summer student, Evelyn Riddell, who lives with type 1 diabetes (T1D) to get her quick tips on how to drink responsibly with T1D.
The Environmental Determinants of Diabetes in the Young (TEDDY) is following more than 7,000 at-risk children from infancy to 15 years of age to determine the causes of T1D.
Evelyn, our Marketing Communications Assistant for the summer, was featured in the latest bra campaign, and the T1D community is loving it!
Imagine an automated insulin delivery system that is able to connect with other devices seamlessly. A state-of-the-art, tubeless technology that provides continuous insulin therapy, operates on its own platform and publishes its own communication protocol.